Back

Tachycardiomyopathy is associated with metabolic changes that predict LVEF recovery - results from the EMPATHY study

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Atrial fibrillation and heart failure: a deadly combination Pathophysiology and Mechanisms ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor David Heinzmann

Eberhard-Karls University of Tubingen, Tuebingen (Germany)

4 More presentations in this session

Presentation thumbnail
Prognostic implications of atrial fibrillation in young patients without overt heart disease - an early marker of future cardiomyopathy ?
Doctor P. Rasmussen (Copenhagen, DK)
Abstract Slides Video
Presentation thumbnail
Integrating pre- and post-ablation B-type natriuretic peptide to identify high-risk population for long-term adverse events and arrhythmic recurrence in persistent atrial fibrillation
Doctor S. Hashimoto (Ube, JP)
Abstract Slides Video
Presentation thumbnail
ECG changes predict new-onset heart failure in patients with atrial fibrillation.
Doctor C. Binding (Copenhagen, DK)
Abstract Slides Video
Presentation thumbnail
Care and outcomes of atrial fibrillation in potentially vulnerable populations: A 20-year perspective using real-world data
Doctor N. Nouhravesh (Durham, US)
Abstract Slides Video

Access the full session

Session thumbnail
Atrial fibrillation and heart failure: a deadly combination
Video

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Pathophysiology and rationale for CMIs in HCM and HFpEF
thumbnail
Congress Presentation
Mitochondrial cardiomyopathy in two pediatric patients - teamwork is always better
thumbnail
Congress Presentation
Tachycardiomyopathy: long-term characteristics of this novel subsetting of acute heart failure

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources